Skip to main content

Thymus Neuroendocrine Neoplasm clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

    Sorry, in progress, not accepting new patients

    This phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Cabozantinib is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may slow tumor growth.

    San Francisco, California and other locations

Last updated: